Company Filing History:
1 out of 19 
1 out of 5 Years Active: 2024
Title: Alessandra Ottani: Innovator in Melanoma Treatment
Introduction
Alessandra Ottani is a notable inventor based in Modena, Italy. She has made significant contributions to the field of therapeutic treatments, particularly in the area of melanoma and other tumor pathologies. Her innovative work has the potential to impact cancer treatment significantly.
Latest Patents
Alessandra holds a patent for "Melanocortin agents for use in the therapeutic treatment of melanoma, tumors of the gastrointestinal tract, and thyroid carcinoma." This patent describes a method of therapeutic treatment that includes administering melanocortin receptor-4 (MC4R) antagonists to patients suffering from these conditions. The patent emphasizes the use of these antagonists in targeted anti-tumor treatments, particularly in adjuvant therapies that affect the onset and progression of tumor metastasis. Additionally, it includes a pharmaceutical composition that combines MC4R antagonists with suitable vehicles and optional adjuvants.
Career Highlights
Throughout her career, Alessandra has worked with prestigious institutions such as the University of Pisa and the University of Modena and Reggio Emilia. Her research and innovations have garnered attention in the medical community, particularly for their implications in cancer therapy.
Collaborations
Alessandra has collaborated with notable colleagues, including Guido Bocci and Teresa Di Desidero. These partnerships have contributed to her research and the development of her patented treatments.
Conclusion
Alessandra Ottani's work in the field of melanoma treatment showcases her dedication to advancing medical science. Her innovative approaches and collaborations highlight the importance of research in developing effective therapies for cancer patients.